Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Bipolar Depression
NCT01717040Phase 4Terminated
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Sep 2012
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in bipolar disorder (BD), sponsored by University Hospitals Cleveland Medical Center. Started Sep 2012; status: terminated.
02
Drugs
pioglitazone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01717040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01717040.